BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12223078)

  • 1. Tissue factor - a therapeutic target for thrombotic disorders.
    Houston DS
    Expert Opin Ther Targets; 2002 Apr; 6(2):159-74. PubMed ID: 12223078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formation.
    Girard TJ; Nicholson NS
    Curr Opin Pharmacol; 2001 Apr; 1(2):159-63. PubMed ID: 11714090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
    Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
    Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
    Del Turco S; De Caterina R
    Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.
    Grover SP; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):709-725. PubMed ID: 29437578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
    Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X
    Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tissue factor as an antithrombotic strategy.
    Golino P; Cimmino G
    Semin Vasc Med; 2003 May; 3(2):205-14. PubMed ID: 15199484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
    Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
    Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor.
    Lee AY; Vlasuk GP
    J Intern Med; 2003 Oct; 254(4):313-21. PubMed ID: 12974870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
    Sørensen BB; Rao LV
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits.
    Chi L; Gibson G; Peng YW; Bousley R; Brammer D; Rekhter M; Chen J; Leadley R
    J Thromb Haemost; 2004 Jan; 2(1):85-92. PubMed ID: 14717971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action.
    Rao LV; Ezban M
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S135-43. PubMed ID: 10850580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway.
    McVey JH
    Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.
    Hembrough TA; Swartz GM; Papathanassiu A; Vlasuk GP; Rote WE; Green SJ; Pribluda VS
    Cancer Res; 2003 Jun; 63(11):2997-3000. PubMed ID: 12782609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
    Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
    Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
    Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Factor VIIa/tissue factor.
    Shirk RA; Vlasuk GP
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma.
    Gerotziafas GT; Elalamy I; Depasse F; Chakroun T; Bara L; Arzoglou P; Samama MM
    Blood Coagul Fibrinolysis; 2003 Oct; 14(7):633-8. PubMed ID: 14517487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.